cladribine has been researched along with Thrombopenia in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 18 (64.29) | 18.2507 |
| 2000's | 6 (21.43) | 29.6817 |
| 2010's | 4 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dahm, AEA; Dybedal, I; Habberstad, AH; Randen, U; Spetalen, S; Tjønnfjord, GE; Tran, HTT | 1 |
| Blonski, JZ; Calbecka, M; Ceglarek, B; Chojnowski, K; Dmoszynska, A; Dwilewicz-Trojaczek, J; Gora-Tybor, J; Hellmann, A; Kloczko, J; Kostyra, A; Kowal, M; Kuliczkowski, K; Lewandowski, K; Mital, A; Nowak, W; Potoczek, S; Robak, T; Seferynska, I; Skotnicki, A; Stella-Holowiecka, B; Sulek, K; Trelinski, J; Warzocha, K; Wiater, E; Zawilska, K | 1 |
| Chao, Z; Chen, XM; Deng, CX; DU, X; Huang, X; Lai, PL; Li, MM; Liao, PJ; Ling, W; Lu, ZS; Wan, CC; Wang, YL; Weng, JY; Wu, SJ; Zhong, LY; Zou, XL | 1 |
| Schmidt, S | 1 |
| D'Silva, R; Papish, S; Tousi, B | 1 |
| Błoński, JZ; Dwilewicz-Trojaczek, J; Góra-Tybor, J; Kasznicki, M; Robak, T; Stella-Hołowiecka, B; Wołowiec, D | 1 |
| Di Raimondo, F; Ferrajoli, A; Keating, MJ; Lerner, S; Montillo, M; Morra, E; O'Brien, S; Tedeschi, A | 1 |
| Daugherty, CK; Huo, D; Janisch, L; Larson, RA; Odenike, OM; Ratain, MJ; Sobecks, RM; Zimmerman, TM | 1 |
| Ellison, D; Emanuele, S; Kosty, M; Koziol, J; Piro, L; Saven, A | 1 |
| Burris, HA; Eckardt, JR; Fields, S; Kuhn, JG; Rizzo, J; Rodriguez, GI; Smith, LS; VanDenBerg, K; von Hoff, DD; Weiss, GR | 1 |
| Beutler, E; Kosty, M; Lemon, RH; Piro, LD; Saven, A | 1 |
| Andreeff, M; Beran, M; Estey, E; Kantarjian, H; Keating, M; Koller, C; O'Brien, S; Pierce, S; Robertson, B | 1 |
| Kobayashi, K; O'Brien, SM; Ratain, MJ; Schilsky, RL; Vogelzang, NJ; Vokes, EE | 1 |
| Delannoy, A; Doyen, C; Ferrant, A; Martiat, P; Michaux, JL; Montfort, L; Sokal, G | 1 |
| Bosly, A; Delannoy, A; Ferrant, A; Martiat, P; Michaux, JL; Zenebergh, A | 1 |
| Bashford, J; Bunce, I; Dodds, A; Eliadis, P; Firkin, F; Frost, T; Goldstein, D; Grigg, A; Kelly, C; Kimber, R; Lee, N; Lowenthal, R; Moore, D; Morton, J; Mulligan, S; Parkin, J; Rentoul, A; Rodwell, R; Rooney, K; Stone, J; Taylor, K; Wright, S | 1 |
| Hellmann, A; Lewandowski, K; Pawlik, H; Siedlewicz, A; Zaucha, JM | 1 |
| Juliusson, G; Liliemark, J; Porwit, A | 1 |
| Hilgenfeld, E; Jäger, U; Knauf, WU; Mitterbauer, M; Wilfing, A | 1 |
| Hotta, T; Kinoshita, T; Kobayashi, Y; Kozuru, M; Narabayashi, M; Ogura, M; Ohashi, Y; Suzuki, R; Tobinai, K; Uike, N | 1 |
| Betticher, DC; Cerny, T; Egger, T; Fey, MF; Hess, U; Hsu Schmitz, SF; Pugin, P; Ratschiller, D; Stalder, M; von Rohr, A | 1 |
| Abramson, N; Marks, AR | 1 |
| Cavallin-Ståhl, E; Juliusson, G; Liliemark, J; Martinsson, U; Porwit, A; Strömberg, M; Svedmyr, E | 1 |
| Błasińska-Morawiec, M; Błoński, J; Dmoszyńska, A; Dwilewicz-Trojaczek, J; Hansz, J; Hałaburda, K; Hellmann, A; Hołowiecki, J; Konopka, L; Kotlarek-Haus, S; Potoczek, S; Robak, T; Skotnicki, AB; Urasiński, I; Zdziarska, B | 1 |
| Arceci, R; Lipton, JM; Wayne, AS; Weitzman, S; Whitlock, JA | 1 |
| Blasińska-Morawiec, M; Bloński, JZ; Ceglarek, B; Dmoszyńska, A; Dwilewicz-Trojaczek, J; Grieb, P; Hellmann, A; Kasznicki, M; Konopka, L; Kotlarek-Haus, S; Krykowski, E; Maj, S; Mrugala-Spiewak, H; Nowak, W; Potoczek, S; Robak, T; Skotnicki, AB; Urasiński, I; Zdziarska, B | 1 |
| Braylan, RC; Cornfield, DB; Mitchell Nelson, DM; Moller-Patti, D; Rimsza, LM | 1 |
| Juliusson, G; Liliemark, J | 1 |
3 review(s) available for cladribine and Thrombopenia
| Article | Year |
|---|---|
[Oral cladribine for relapsing-remitting multiple sclerosis: another purine analogue or a genuine therapeutic innovation?].
Topics: Administration, Oral; Adverse Drug Reaction Reporting Systems; Animals; Azathioprine; Cladribine; Clinical Trials, Phase III as Topic; Disability Evaluation; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Long-Term Care; Lymphopenia; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neoplasms; Pregnancy; Purine Nucleosides; Randomized Controlled Trials as Topic; Thrombocytopenia | 2010 |
Is there a place for 2-CDA in the treatment of B-CLL?
Topics: Antineoplastic Agents; Cladribine; Clinical Trials as Topic; Drug Resistance, Neoplasm; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Recurrence; Thrombocytopenia; Vidarabine | 1997 |
Nucleoside analogues in the therapy of Langerhans cell histiocytosis: a survey of members of the histiocyte society and review of the literature.
Topics: Adolescent; Adult; Age of Onset; Antibiotics, Antineoplastic; Antineoplastic Agents; Child; Child, Preschool; Cladribine; Data Collection; Female; Histiocytosis, Langerhans-Cell; Humans; Infant; Liver; Male; Pentostatin; Thrombocytopenia; Treatment Outcome | 1999 |
15 trial(s) available for cladribine and Thrombopenia
| Article | Year |
|---|---|
Immune thrombocytopenia in patients with chronic lymphocytic leukemia treated with cladribine-based regiments or chlorambucil--follow-up of PALG-CLL randomized trials.
Topics: Aged; Chlorambucil; Cladribine; Female; Follow-Up Studies; Hemorrhage; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Prevalence; Retrospective Studies; Thrombocytopenia; Time Factors; Treatment Outcome | 2013 |
Cladribine combined with cyclophosphamide is highly effective in the treatment of chronic lymphocytic leukemia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cyclophosphamide; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoplasm, Residual; Neutropenia; Opportunistic Infections; Remission Induction; Survival Analysis; Thrombocytopenia; Treatment Outcome | 2002 |
Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cyclophosphamide; Disease-Free Survival; Female; Humans; Infusions, Intravenous; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic; Leukopenia; Male; Middle Aged; Neoplasm Staging; Neutropenia; Salvage Therapy; Thrombocytopenia; Treatment Outcome | 2003 |
A phase I trial of gemcitabine plus cladribine in patients with advanced hematologic malignant diseases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Deoxycytidine; Drug Administration Schedule; Fatigue; Feasibility Studies; Female; Gemcitabine; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Thrombocytopenia | 2004 |
2-Chlorodeoxyadenosine activity in patients with untreated, indolent non-Hodgkin's lymphoma.
Topics: Actuarial Analysis; Adult; Aged; Aged, 80 and over; Anemia; Cladribine; Disease-Free Survival; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Neutropenia; Recurrence; Survival Rate; Thrombocytopenia; Time Factors | 1995 |
A phase I and pharmacokinetics study of 2-chlorodeoxyadenosine in patients with solid tumors.
Topics: Adult; Aged; Agranulocytosis; Anemia; Cell Count; Chromatography, High Pressure Liquid; Cladribine; Colorectal Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Lymphopenia; Male; Middle Aged; Neoplasms; Neutrophils; Thrombocytopenia | 1995 |
2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemia.
Topics: Adult; Aged; Cladribine; Female; Follow-Up Studies; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Remission Induction; Thrombocytopenia | 1995 |
A phase I study of intermittent infusion cladribine in patients with solid tumors.
Topics: Adult; Aged; Blindness; Carcinoma, Non-Small-Cell Lung; Cladribine; Colorectal Neoplasms; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Neutropenia; Thrombocytopenia | 1994 |
2-Chlorodeoxyadenosine therapy in advanced chronic lymphocytic leukaemia.
Topics: Aged; Cladribine; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neutropenia; Remission Induction; Salvage Therapy; Seizures; Survival Rate; Thrombocytopenia; Treatment Outcome | 1994 |
2-Chlorodeoxyadenosine therapy in Waldenstrom's macroglobulinaemia.
Topics: Aged; Aged, 80 and over; Cladribine; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neutropenia; Remission Induction; Salvage Therapy; Survival Rate; Thrombocytopenia; Treatment Outcome; Waldenstrom Macroglobulinemia | 1994 |
Intermittent infusion of cladribine (CdA) in previously treated patients with low-grade non-Hodgkin's lymphoma.
Topics: Cladribine; Disease Progression; Dose-Response Relationship, Drug; Humans; Infections; Leukopenia; Lymphoma, Non-Hodgkin; Survival Rate; Thrombocytopenia | 1997 |
Phase I study of cladribine (2-chlorodeoxyadenosine) in lymphoid malignancies. Cladribine Study Group.
Topics: Aged; Antineoplastic Agents; Cladribine; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neutropenia; Thrombocytopenia | 1997 |
Cladribine (2-CDA) given as subcutaneous bolus injections is active in pretreated Waldenström's macroglobulinaemia. Swiss Group for Clinical Cancer Research (SAKK).
Topics: Adult; Aged; Aged, 80 and over; Cladribine; Female; Humans; Immunosuppressive Agents; Injections, Intradermal; Male; Middle Aged; Neutropenia; Opportunistic Infections; Thrombocytopenia; Treatment Outcome; Waldenstrom Macroglobulinemia | 1997 |
Cladribine for untreated or early low-grade non-Hodgkin's lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cell Transformation, Neoplastic; Cladribine; Disease Progression; Female; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Lymphopenia; Male; Middle Aged; Platelet Count; Survival Analysis; Thrombocytopenia; Treatment Outcome | 1998 |
Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cladribine; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Incidence; Infections; Leukemia, Lymphocytic, Chronic, B-Cell; Life Tables; Male; Middle Aged; Neutropenia; Poland; Prednisone; Prospective Studies; Remission Induction; Survival Rate; Thrombocytopenia; Treatment Outcome | 2000 |
10 other study(ies) available for cladribine and Thrombopenia
| Article | Year |
|---|---|
Neutropenia caused by hairy cell leukemia in a patient with myelofibrosis secondary to polycythemia vera: a case report.
Topics: Aged; Antineoplastic Agents; Biomarkers, Tumor; Bone Marrow; Cladribine; Disease Progression; Fatal Outcome; Humans; Janus Kinase 2; Leukemia, Hairy Cell; Leukemia, Myeloid, Acute; Leukopenia; Male; Neutropenia; Oral Ulcer; Polycythemia Vera; Primary Myelofibrosis; Splenomegaly; Thrombocytopenia | 2018 |
[Effectiveness of CLAT Protocol for Treating Patients with Refractory Acute Myeloid Leukemia].
Topics: Adolescent; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cytarabine; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction; Thrombocytopenia; Topotecan; Young Adult | 2016 |
Systemic vasculitis complicating hairy cell leukaemia treatment with cladribine.
Topics: Aged; Cladribine; Female; Humans; Leukemia, Hairy Cell; Renal Insufficiency; Thrombocytopenia; Treatment Outcome; Vasculitis | 2002 |
Lack of effect of 2-chlorodeoxyadenosine therapy in patients with chronic lymphocytic leukemia refractory to fludarabine therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neutropenia; Remission Induction; Thrombocytopenia; Vidarabine | 1994 |
High response rates with short infusional 2-chlorodeoxyadenosine in de novo and relapsed low-grade lymphoma. Australian and New Zealand Lymphoma Study Group.
Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukopenia; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Opportunistic Infections; Recurrence; Survival Analysis; Thrombocytopenia; Treatment Outcome | 1996 |
2-Chlorodeoxyadenosine treatment in the Sezary syndrome.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Cladribine; Female; Humans; Infections; Male; Middle Aged; Neutropenia; Sezary Syndrome; Thrombocytopenia; Treatment Failure | 1997 |
Effect of 2-CDA on thrombocytopenia in myelofibrosis.
Topics: Cladribine; Humans; Immunosuppressive Agents; Primary Myelofibrosis; Thrombocytopenia | 1998 |
2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Cohort Studies; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Neoplasms, Second Primary; Neutropenia; Poland; Survival Rate; Thrombocytopenia; Time Factors; Treatment Outcome | 1999 |
The diagnosis of hairy cell leukemia can be established by flow cytometric analysis of peripheral blood, even in patients with low levels of circulating malignant cells.
Topics: Adult; Aged; Antigens, CD; Antineoplastic Agents; Biomarkers; Cladribine; Female; Flow Cytometry; Humans; Immunophenotyping; Leukemia, Hairy Cell; Leukopenia; Male; Middle Aged; Neoplastic Cells, Circulating; Thrombocytopenia; Treatment Outcome | 2001 |
Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2'-deoxyadenosine (CdA): relation to opportunistic infections.
Topics: 2-Chloroadenosine; Antineoplastic Agents; Candidiasis; Cladribine; Cytomegalovirus Infections; Deoxyadenosines; Humans; Immunophenotyping; Leukemia, Hairy Cell; Leukopenia; Lymphocytes; Monocytes; Neutrophils; Opportunistic Infections; Remission Induction; Thrombocytopenia | 1992 |